FDA Wants More Regulatory Power After Meningitis Outbreak
Outbreak has killed at least 32
The Food and Drug Administration is seeking greater authority to regulate drug makers such as the Massachusetts company that produced steroid injections tied to a deadly outbreak of fungal meningitis, officials said Wednesday at a congressional hearing in which one of the firm's owners invoked his constitutional rights and refused to testify.
Barry Cadden, a co-founder of the New England Compounding Center in Framingham, Mass., briefly appeared before the House Energy and Commerce oversight subcommittee hearing. In a dramatic moment during the televised proceeding, Cadden refused to discuss his company's role in an outbreak that has killed at least 32 people.
"Under advice of counsel, I respectfully decline to answer under basis of my constitutional rights and privileges, including the 5th Amendment," Cadden said citing his right to avoid self-incrimination.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?